JP2003246735A5 - - Google Patents

Download PDF

Info

Publication number
JP2003246735A5
JP2003246735A5 JP2002366375A JP2002366375A JP2003246735A5 JP 2003246735 A5 JP2003246735 A5 JP 2003246735A5 JP 2002366375 A JP2002366375 A JP 2002366375A JP 2002366375 A JP2002366375 A JP 2002366375A JP 2003246735 A5 JP2003246735 A5 JP 2003246735A5
Authority
JP
Japan
Prior art keywords
active ingredient
tetrahydrothieno
cyclopropylcarbonyl
fluorobenzyl
acetoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002366375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003246735A (ja
JP4029974B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002366375A priority Critical patent/JP4029974B2/ja
Priority claimed from JP2002366375A external-priority patent/JP4029974B2/ja
Publication of JP2003246735A publication Critical patent/JP2003246735A/ja
Publication of JP2003246735A5 publication Critical patent/JP2003246735A5/ja
Application granted granted Critical
Publication of JP4029974B2 publication Critical patent/JP4029974B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002366375A 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬 Expired - Lifetime JP4029974B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002366375A JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001388757 2001-12-21
JP2001-388757 2001-12-21
JP2002366375A JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Publications (3)

Publication Number Publication Date
JP2003246735A JP2003246735A (ja) 2003-09-02
JP2003246735A5 true JP2003246735A5 (enrdf_load_stackoverflow) 2005-06-09
JP4029974B2 JP4029974B2 (ja) 2008-01-09

Family

ID=28676969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002366375A Expired - Lifetime JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Country Status (1)

Country Link
JP (1) JP4029974B2 (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2672154C (en) 2006-12-07 2014-11-18 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved storage stability
WO2008072535A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
JP5433235B2 (ja) * 2006-12-07 2014-03-05 第一三共株式会社 固形製剤の製造方法
JPWO2008069262A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 安定性が改善されたフィルムコーティング製剤
CN101600430A (zh) 2006-12-07 2009-12-09 第一三共株式会社 含有甘露糖醇或乳糖的固体药物制剂
WO2008108291A1 (ja) * 2007-03-02 2008-09-12 Daiichi Sankyo Company, Limited 高純度のプラスグレル塩酸塩の製造方法
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
WO2011158931A1 (ja) * 2010-06-17 2011-12-22 協和発酵キリン株式会社 インダゾール誘導体の有用な塩
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
EP2409685A3 (en) * 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
TR201007926A1 (tr) * 2010-07-19 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Prasugrel tablet formülasyonları.
CN102775422B (zh) * 2012-03-13 2014-12-31 山东新华制药股份有限公司 普拉格雷中间体的一种晶型
CN104592250B (zh) * 2015-01-15 2016-05-11 新发药业有限公司 一种低成本的普拉格雷的环保制备方法

Similar Documents

Publication Publication Date Title
JP2003246735A5 (enrdf_load_stackoverflow)
BR0112168A (pt) Composto, sais de adição de ácido de 2-acetoxi-5- (a-ciclopropilcarbonil-2-fluorbenzil) -4,5,6,7-tetrahidrotieno [3,2-c]piridina, medicamento, métodos para prevenção ou tratamento de doenças induzidas pela formação de trombos ou induzidas por embolização em um animal de sangue quente, e para a prevenção ou tratamento de trombose ou embolismo em um humano, e, processos para a preparação de sal de adição de ácido, e de cloridreto de 2-acetoxi-5- (a-ciclopropilcarbonil-2-fluorbenzil) -4,5,6,7-tetrahidrotieno [3,2-c] piridina
RU2003118638A (ru) Медицинские композиции, содержащие аспирин
WO2005065646A3 (en) Novel drug compositions and dosage forms
CY1108626T1 (el) Ιαματικες συνθεσεις που περιεχουν ασπιρινη
ZA200409862B (en) Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
PT833618E (pt) Forma farmaceutica solida para utilizacao oral
ATE331525T1 (de) Salzformarme polyallylamine
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
HRP20130159T1 (hr) Roskovitin, namijenjen lijeäśenju izvjesnih cistiäśnih bolesti
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
AU8799001A (en) Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
HRP20050497B1 (hr) Uporaba levocetirizina za liječenje stalnog alergijskog rinitisa
NO20031030L (no) Nye krystaller av N-hydroksy-2(S)-metyl-5-etoksymetoksy-4(S)- [N-(4-fenoksyfenylkarbonyl)amino]pentanamid, fremgangsmåte for deresfremstilling og medisinerinneholdende krystallene som den aktive bestanddel
FR2861300B1 (fr) Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique
Vet—QA02BC02 1760 Gastrointestinal Drugs
TH77070A (th) สารผสมทางเภสัชกรรมสำหรับการรักษาอาการโรคของทางเดินปัสสาวะส่วนล่าง
RU2003106097A (ru) Способ управляемого снижения агрегационной активности тромбоцитов в эксперименте
TH51774A (th) สารสำเร็จรูปเชิงเภสัชกรรม